Profile image
Senior Lecturer

Dr Lise Lafferty

  • PhD, The Kirby Institute, UNSW Sydney (2017)
  • Master of Indigenous Studies, UNSW Sydney (2011)
  • Master of (International) Social Development, UNSW Sydney (2011)

 

E-mail
l.lafferty@unsw.edu.au
Location
Treloar C; Lancaster K; Rhodes T; Lafferty L; Bryant J; Rance J, 2024, 'The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13845
2024
Lafferty L; Beadman M; Ward J; Flynn E; Hosseini-Hooshyar S; Martinello M; Treloar C, 2024, 'Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia', International Journal of Drug Policy, 125, http://dx.doi.org/10.1016/j.drugpo.2024.104335
2024
Treloar C; Rance J; Bryant J; Lafferty L, 2024, '‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia', Journal of Viral Hepatitis, 31, pp. 59 - 65, http://dx.doi.org/10.1111/jvh.13896
2024
Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
2023
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
2023
Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J, 2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644, http://dx.doi.org/10.1016/j.jhep.2023.04.019
2023
Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
2023
Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925
2023
Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.', J Subst Use Addict Treat, 150, pp. 209066, http://dx.doi.org/10.1016/j.josat.2023.209066
2023
Broom A; Peterie M; Ridge D; Lafferty L; Kenny K; Broom J; Kelly-Hanku A; Treloar C; Applegate T, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
2023
Storer D; Lafferty L; Graham S; Murphy D; Rance J; Brener L; Seale H; Hammoud MA; Prestage G; Beadman M; Gardner K; Blaxland M; Bolt R; Caruana T; Philpot S; Rule J; Bryant J, 2023, 'Perceptions of COVID-19 Vaccines: Lessons from Selected Populations Who Experience Discrimination in the Australian Healthcare System', Health & Social Care in the Community, 2023, pp. 1 - 10, http://dx.doi.org/10.1155/2023/5901128
2023
Peterie M; Broom A; Kenny K; Broom J; Regan D; Lafferty L; Kelly-Hanku A; Treloar C, 2023, 'Economies of resistance', Critical Public Health, 33, pp. 763 - 775, http://dx.doi.org/10.1080/09581596.2023.2271140
2023
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
2022
Lafferty L, 2022, 'Navigating the dynamics of trust, rapport and power while conducting social health research with people in prison', Qualitative Social Work, 22, pp. 1222 - 1236, http://dx.doi.org/10.1177/14733250221122301
2022
Bryant J; Horwitz R; Gray RM; Lafferty L; Jops P; Blunden H; Hudson S; Brener L, 2022, 'Improving access to drug and alcohol treatment in NSW Australia: The role of self-determination and peer support', Health and Social Care in the Community, 30, pp. e2050 - e2057, http://dx.doi.org/10.1111/hsc.13639
2022
Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456
2022
Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571, http://dx.doi.org/10.1016/j.drugpo.2021.103571
2022
Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
2022
Hill AO; Bavinton BR; Kaneko N; Lafferty L; Lyons A; Gilmour S; Armstrong G, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, 50, pp. 3103 - 3113, http://dx.doi.org/10.1007/s10508-021-02097-3
2021
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
2021
Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
2021
Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, 21, pp. 1503, http://dx.doi.org/10.1186/s12889-021-11554-6
2021
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
2021
Lafferty L; Smith K; Causer L; Andrewartha K; Whiley D; Badman SG; Donovan B; Anderson L; Tangey A; Mak D; Maher L; Shephard M; Guy R; Bastian L; Ward J; Kaldor J; Comerford C; Bushby T; Moore L; Gunathilake M; Johnson D; Gallant D, 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers and facilitators', Implementation Science Communications, 2, pp. 127, http://dx.doi.org/10.1186/s43058-021-00232-8
2021
Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469
2021
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106
2020
Camara H; Zhang Y; Lafferty L; Vallely A; Guy R; Kelly-Hanku A, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/21093
2020
Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
2020
Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
2020
Settumba SN; Shanahan M; Butler T; Schofield P; Lafferty L; Simpson P; Chambers G, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy, http://dx.doi.org/10.1007/s40258-019-00484-5
2019
Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
2019
Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
2018
hilferty F; Lafferty L; valentine K; Cale J; Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, 5th edition, pp. 34 - 47, https://icpa.org/library/a-preview-of-the-advancing-corrections-journal-edition-5-2018/
2018
Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6
2018
Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
2018
Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
2018
Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
2017
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627
2017
Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040
2016
Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, 4, pp. 9, http://dx.doi.org/10.1186/s40352-016-0040-z
2016
Lafferty L; Chambers GM; Guthrie J; Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8
2015
Lafferty L; Thomas J; Gare J; Watts C; Marshall A, 2023, Speed geeking: how speed-dating techniques can tackle power imbalances at conferences, Nature, , http://dx.doi.org/10.1038/d41586-023-01866-5
2023
Drysdale K (ed.), 2021, The Hard Cell: Living Life on the Outside. The Hard Cell: Living Life on the Outside. Story 1: Exhaustion Story 2: Reflections Story 3: Hate this, Centre for Social Research in Health, UNSW Sydney, Sydney, Australia, , https://www.youtube.com/watch?v=njTVEBehDjQ;%20https://www.youtube.com/watch?v=70Ctgo-rkGw%20;%20https://www.youtube.com/watch?v=2oNT7u3vJ98
2021
Broady T; Cama E; Rance J; Lafferty L; Brener L; Treloar C; Holt M; Mao L, 2023, Annual Report of Trends in Behaviour 2023: Viral Hepatitis, HIVSTIs and Sexual Health in Australia, Centre for Social Research in Health, UNSW Sydney., Sydney, http://dx.doi.org/10.26190/zk8f-3z85
2023
Patel P; Rautenbach C; Lafferty L, 2022, An Evaluation of MyCheck (BBV/STI e-testing pathway), The Kirby Institute, UNSW Sydney and The NSW Ministry of Health, Sydney, http://dx.doi.org/10.26190/unsworks/28347
2022
Lafferty L; Whitford K; Whybrow B; Haire B, 2022, Girinyalanha Giilang (Talking About A Story): A qualitative study exploring barriers and enablers to sexual health information and services among young Aboriginal people in Murrumbidgee, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/yxzv-ag25
2022
Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal and Torres Strait Islander people in Murrumbidgee Local Health District Community Report, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/zrtw-n718, https://healthinfonet.ecu.edu.au/learn/health-topics/sexual-health/safe-sex/publications/45754/?title=Girinyalanha+giilang+%28talking+about+a+story%29%3A+enablers+and+barriers+to+sexual+health+resources+among+young+Aboriginal+and+Torres+Strait+Islander+people+in+Murrumbidgee+Local+Health+District&contentid=45754_1
2022
Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal people in Murrumbidgee Local Health District Summary Report, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/hphx-h503, https://healthinfonet.ecu.edu.au/learn/health-topics/sexual-health/safe-sex/publications/45754/?title=Girinyalanha+giilang+%28talking+about+a+story%29%3A+enablers+and+barriers+to+sexual+health+resources+among+young+Aboriginal+and+Torres+Strait+Islander+people+in+Murrumbidgee+Local+Health+District&contentid=45754_1
2022
Bryant J; Murphy D; Rance J; Storer D; Lafferty L; Brener L; Seale H; Bolt R, 2021, Summary 1: COVID-19 vaccine acceptability among priority populations, UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/nzkt-a758
2021
Newman CE; Persson A; valentine K; Hamilton M; Bryant J; Wallace J; Drysdale K; Smith AKJ; Gray R; Lafferty L; Botfield J; Rance J; Cui J, 2020, my health, our family: documenting stories of family life in the context of HIV, hepatitis B or hepatitis C (summary report), UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/5facbe6ba9ac8
2020
Bryant J; Horwitz R; Gray R; Lafferty L; Jops P; Blunden H; Brener L, 2020, Barriers and enablers associated with access and equity in alcohol and other drug treatment in NSW, UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/5f1a2d1d11d61
2020
Cale J; Zmudzki F; Hilferty F; Lafferty L; Whitten T; Doyle M; valentine K, 2019, Evaluation of Home Detention in South Australia: Final Report, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/27455, https://www.corrections.sa.gov.au/__data/assets/pdf_file/0006/107961/Evaluation-of-Home-Detention-in-South-Australia-Final-Report.pdf
2019
Bryant J; Gray R; Hull P; Horwitz R; Lafferty L; Mao L; Treloar C, 2019, Research Brief - Understanding barriers and facilitators to the take up of new direct-acting antiviral hepatitis C treatments: The Observe study, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5d647864b9afc
2019
Bryant J; Rance J; Lafferty L; Treloar C, 2018, Annual Report of Trends in Behaviour 2018: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5b57e6eb42bb9
2018
Cale J; Hilferty F; Lafferty L; Zmudzki F; valentine K, 2018, Evaluation of SA Home Detention: research report 1 (baseline analysis), Social Policy Research Centre, UNSW Sydney, Sydney, SPRC Report 21/17, http://dx.doi.org/10.4225/53/5a7a750ec5754
2018
Delaney MT; Hill T; Lafferty L; valentine K; Fotheringham M, 2018, Evaluation of the Wesley's Team Casework Model for SHS Services, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/5aea5a1235f16, http://doi.org/10.4225/53/5aea5a1235f16
2018
Simpson PL; Butler T; Dodson M; Levy M; Kaldor J; Allsop S; Gray D; Wilhelm K; Al-Yaman F; Doyle M; Lafferty L, 2017, The Indigenous Offender Health Research Capacity Building Group Community Report, Kirby Institute, University of New South Wales, National Centre for Indigenous Studies, Australian National University, Winnunga Nimmityjah Aboriginal Health Service, National Drug Research Institute, Curtin University of Technology, Sydney
2017
Bryant J; Rance J; Lafferty L; Treloar C, 2017, Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/597ea9dc4fef2
2017
Lafferty L; Lewis S; Drysdale K; Monaghan R; Kelly-Hanku A; Guy R; Treloar C, 2023, 'Enablers and barriers to scaling up infectious diseases point-of-care testing in the primary care setting in Australia', presented at Australasian Conference on Point of Care Testing for Infectious Diseases, Sydney, 14 March 2023 - 15 March 2023
2023
Patel P; Lafferty L, 2022, 'An evaluation of MyCheck: a digital STI/BBV e-testing platform', presented at ASHM, 29 August 2022 - 01 September 2023
2022
Lafferty L; Schroeder S; Marshall A; Drysdale K; Higgs P; Stoove M; Baldry E; Dietze P; Treloar C, 2022, 'Trust and Service Engagement Among People Who Inject Drugs Post-Release', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Glasgow, Scotland, 19 October 2022 - 21 October 2022
2022
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd A; Treloar C, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
2022
Lafferty L; Rautenbach C; McNulty A; Ryder N; Slattery C; Houghton R; Kenigsberg A; Murray C; Carrington N; Patel P, 2022, 'Client and staff perceptions of acceptability of an alternative telehealth testing pathway at Sydney Sexual Health Centre for bloodborne virus and sexually transmissible infections', presented at Joint Australasian HIV&AIDS and Sexual Health Conferences, Sunshine Coast, 29 August 2022 - 01 September 2022
2022
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
2021
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
2021
Lafferty L; Rance J; Dore G; Lloyd A; Treloar C, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
2021
Lafferty L; Rance J; Treloar C, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019
2019
Lafferty L; Bryant J; Mao L; Hull P; Gray R; Treloar C, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019
2019
Rance J; Lafferty L; Treloar C, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018
2018
Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018
2018
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017
2017
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016
2016
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016
2016
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016
2016
Lafferty LM; Treloar C; Steele M; van Breda N; Hiley S; Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016
2016
Lafferty LM; Treloar C; Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016
2016
Lafferty LM; Guthrie J; Chambers GM; Butler T, 2015, 'Social capital of men in prison living with hepatitis C', presented at 2nd National Complex Needs Conference, 17 November 2015 - 18 November 2015
2015
Lafferty LM; Guthrie J; Chambers GM; Butler T, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013
2013
Lafferty LM, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013
2013
Carrington N; Patel P; Houghton R; Kenigsberg A; Slattery C; Purchas J; Prihaswan P; Browne M; Rautenbach C; Lafferty L; Murray C; Ryder N; McNulty A, 2022, 'MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers.', in MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers., presented at ASHM, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/ae041557ba884b0ca80dffcfbded38bc
2022
Treloar C; Broady T; Drysdale K; Brener L; Schroeder SE; Lafferty L; Marshall AD; Dietze PM; Higgs P; Stoove M; Baldry E, 2022, 'Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S136 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Salmon AM; Silins E; Belackova V; Jauncey M; Day CA; Lafferty L; Wood W, 2018, 'SYMPOSIUM: ABOVE AND BEYOND - AN EXPLORATION OF CARE BEYOND SUPERVISED INJECTIONS AT THE UNITING MEDICALLY SUPERVISED INJECTING CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S14 - S14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Rance J; Lafferty L; Treloar C, 2017, 'P52 ‘Behind closed doors, no one sees, no one knows’: stigma and treatment as prevention in prison', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 30 - 30, http://dx.doi.org/10.1016/s2055-6640(20)30793-7
2017
Lafferty L; Wild C; Rance J; Treloar C, 2017, 'P30 Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia's current policy frameworks', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 22, http://dx.doi.org/10.1016/s2055-6640(20)30771-8
2017
Lafferty L; Rance J; Treloar C, 2017, 'P31 Treatment as prevention in the prison setting: prisoners’ perspectives', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 23, http://dx.doi.org/10.1016/s2055-6640(20)30772-x
2017
Lafferty LM; Butler T, 2017, Relationships Matter: Social Capital Theory and Hepatitis C Treatment Uptake among Men in Prison, http://www.unsworks.unsw.edu.au/UNSWORKS:unsworks_search_scope:unsworks_43422
2017
Rance JA; Lafferty L; Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015
2015
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015
2015

Paul Bourke Award for Early Career Research, Academy of the Social Sciences in Australia (2023)

 

 

Treloar C; Lancaster K; Rhodes T; Lafferty L; Bryant J; Rance J, 2024, 'The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13845
2024
Lafferty L; Beadman M; Ward J; Flynn E; Hosseini-Hooshyar S; Martinello M; Treloar C, 2024, 'Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia', International Journal of Drug Policy, 125, http://dx.doi.org/10.1016/j.drugpo.2024.104335
2024
Treloar C; Rance J; Bryant J; Lafferty L, 2024, '‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia', Journal of Viral Hepatitis, 31, pp. 59 - 65, http://dx.doi.org/10.1111/jvh.13896
2024
Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
2023
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
2023
Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J, 2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644, http://dx.doi.org/10.1016/j.jhep.2023.04.019
2023
Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
2023
Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925
2023
Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.', J Subst Use Addict Treat, 150, pp. 209066, http://dx.doi.org/10.1016/j.josat.2023.209066
2023
Broom A; Peterie M; Ridge D; Lafferty L; Kenny K; Broom J; Kelly-Hanku A; Treloar C; Applegate T, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
2023
Storer D; Lafferty L; Graham S; Murphy D; Rance J; Brener L; Seale H; Hammoud MA; Prestage G; Beadman M; Gardner K; Blaxland M; Bolt R; Caruana T; Philpot S; Rule J; Bryant J, 2023, 'Perceptions of COVID-19 Vaccines: Lessons from Selected Populations Who Experience Discrimination in the Australian Healthcare System', Health & Social Care in the Community, 2023, pp. 1 - 10, http://dx.doi.org/10.1155/2023/5901128
2023
Peterie M; Broom A; Kenny K; Broom J; Regan D; Lafferty L; Kelly-Hanku A; Treloar C, 2023, 'Economies of resistance', Critical Public Health, 33, pp. 763 - 775, http://dx.doi.org/10.1080/09581596.2023.2271140
2023
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
2022
Lafferty L, 2022, 'Navigating the dynamics of trust, rapport and power while conducting social health research with people in prison', Qualitative Social Work, 22, pp. 1222 - 1236, http://dx.doi.org/10.1177/14733250221122301
2022
Bryant J; Horwitz R; Gray RM; Lafferty L; Jops P; Blunden H; Hudson S; Brener L, 2022, 'Improving access to drug and alcohol treatment in NSW Australia: The role of self-determination and peer support', Health and Social Care in the Community, 30, pp. e2050 - e2057, http://dx.doi.org/10.1111/hsc.13639
2022
Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456
2022
Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571, http://dx.doi.org/10.1016/j.drugpo.2021.103571
2022
Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
2022
Hill AO; Bavinton BR; Kaneko N; Lafferty L; Lyons A; Gilmour S; Armstrong G, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, 50, pp. 3103 - 3113, http://dx.doi.org/10.1007/s10508-021-02097-3
2021
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
2021
Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
2021
Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, 21, pp. 1503, http://dx.doi.org/10.1186/s12889-021-11554-6
2021
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
2021
Lafferty L; Smith K; Causer L; Andrewartha K; Whiley D; Badman SG; Donovan B; Anderson L; Tangey A; Mak D; Maher L; Shephard M; Guy R; Bastian L; Ward J; Kaldor J; Comerford C; Bushby T; Moore L; Gunathilake M; Johnson D; Gallant D, 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers and facilitators', Implementation Science Communications, 2, pp. 127, http://dx.doi.org/10.1186/s43058-021-00232-8
2021
Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469
2021
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106
2020
Camara H; Zhang Y; Lafferty L; Vallely A; Guy R; Kelly-Hanku A, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/21093
2020
Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
2020
Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
2020
Settumba SN; Shanahan M; Butler T; Schofield P; Lafferty L; Simpson P; Chambers G, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy, http://dx.doi.org/10.1007/s40258-019-00484-5
2019
Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
2019
Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
2018
hilferty F; Lafferty L; valentine K; Cale J; Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, 5th edition, pp. 34 - 47, https://icpa.org/library/a-preview-of-the-advancing-corrections-journal-edition-5-2018/
2018
Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6
2018
Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
2018
Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
2018
Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
2017
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627
2017
Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040
2016
Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, 4, pp. 9, http://dx.doi.org/10.1186/s40352-016-0040-z
2016
Lafferty L; Chambers GM; Guthrie J; Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8
2015
Lafferty L; Thomas J; Gare J; Watts C; Marshall A, 2023, Speed geeking: how speed-dating techniques can tackle power imbalances at conferences, Nature, , http://dx.doi.org/10.1038/d41586-023-01866-5
2023
Drysdale K (ed.), 2021, The Hard Cell: Living Life on the Outside. The Hard Cell: Living Life on the Outside. Story 1: Exhaustion Story 2: Reflections Story 3: Hate this, Centre for Social Research in Health, UNSW Sydney, Sydney, Australia, , https://www.youtube.com/watch?v=njTVEBehDjQ;%20https://www.youtube.com/watch?v=70Ctgo-rkGw%20;%20https://www.youtube.com/watch?v=2oNT7u3vJ98
2021
Broady T; Cama E; Rance J; Lafferty L; Brener L; Treloar C; Holt M; Mao L, 2023, Annual Report of Trends in Behaviour 2023: Viral Hepatitis, HIVSTIs and Sexual Health in Australia, Centre for Social Research in Health, UNSW Sydney., Sydney, http://dx.doi.org/10.26190/zk8f-3z85
2023
Patel P; Rautenbach C; Lafferty L, 2022, An Evaluation of MyCheck (BBV/STI e-testing pathway), The Kirby Institute, UNSW Sydney and The NSW Ministry of Health, Sydney, http://dx.doi.org/10.26190/unsworks/28347
2022
Lafferty L; Whitford K; Whybrow B; Haire B, 2022, Girinyalanha Giilang (Talking About A Story): A qualitative study exploring barriers and enablers to sexual health information and services among young Aboriginal people in Murrumbidgee, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/yxzv-ag25
2022
Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal and Torres Strait Islander people in Murrumbidgee Local Health District Community Report, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/zrtw-n718, https://healthinfonet.ecu.edu.au/learn/health-topics/sexual-health/safe-sex/publications/45754/?title=Girinyalanha+giilang+%28talking+about+a+story%29%3A+enablers+and+barriers+to+sexual+health+resources+among+young+Aboriginal+and+Torres+Strait+Islander+people+in+Murrumbidgee+Local+Health+District&contentid=45754_1
2022
Lafferty L; Whitford K; Whybrow B; Williams S; Nikitas A; Haire B, 2022, Girinyalanha Giilang (Talking about a Story): Enablers and barriers to sexual health resources among young Aboriginal people in Murrumbidgee Local Health District Summary Report, The Kirby Institute, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/hphx-h503, https://healthinfonet.ecu.edu.au/learn/health-topics/sexual-health/safe-sex/publications/45754/?title=Girinyalanha+giilang+%28talking+about+a+story%29%3A+enablers+and+barriers+to+sexual+health+resources+among+young+Aboriginal+and+Torres+Strait+Islander+people+in+Murrumbidgee+Local+Health+District&contentid=45754_1
2022
Bryant J; Murphy D; Rance J; Storer D; Lafferty L; Brener L; Seale H; Bolt R, 2021, Summary 1: COVID-19 vaccine acceptability among priority populations, UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/nzkt-a758
2021
Newman CE; Persson A; valentine K; Hamilton M; Bryant J; Wallace J; Drysdale K; Smith AKJ; Gray R; Lafferty L; Botfield J; Rance J; Cui J, 2020, my health, our family: documenting stories of family life in the context of HIV, hepatitis B or hepatitis C (summary report), UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/5facbe6ba9ac8
2020
Bryant J; Horwitz R; Gray R; Lafferty L; Jops P; Blunden H; Brener L, 2020, Barriers and enablers associated with access and equity in alcohol and other drug treatment in NSW, UNSW Centre for Social Research in Health, Sydney, http://dx.doi.org/10.26190/5f1a2d1d11d61
2020
Cale J; Zmudzki F; Hilferty F; Lafferty L; Whitten T; Doyle M; valentine K, 2019, Evaluation of Home Detention in South Australia: Final Report, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/unsworks/27455, https://www.corrections.sa.gov.au/__data/assets/pdf_file/0006/107961/Evaluation-of-Home-Detention-in-South-Australia-Final-Report.pdf
2019
Bryant J; Gray R; Hull P; Horwitz R; Lafferty L; Mao L; Treloar C, 2019, Research Brief - Understanding barriers and facilitators to the take up of new direct-acting antiviral hepatitis C treatments: The Observe study, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5d647864b9afc
2019
Bryant J; Rance J; Lafferty L; Treloar C, 2018, Annual Report of Trends in Behaviour 2018: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5b57e6eb42bb9
2018
Cale J; Hilferty F; Lafferty L; Zmudzki F; valentine K, 2018, Evaluation of SA Home Detention: research report 1 (baseline analysis), Social Policy Research Centre, UNSW Sydney, Sydney, SPRC Report 21/17, http://dx.doi.org/10.4225/53/5a7a750ec5754
2018
Delaney MT; Hill T; Lafferty L; valentine K; Fotheringham M, 2018, Evaluation of the Wesley's Team Casework Model for SHS Services, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/5aea5a1235f16, http://doi.org/10.4225/53/5aea5a1235f16
2018
Simpson PL; Butler T; Dodson M; Levy M; Kaldor J; Allsop S; Gray D; Wilhelm K; Al-Yaman F; Doyle M; Lafferty L, 2017, The Indigenous Offender Health Research Capacity Building Group Community Report, Kirby Institute, University of New South Wales, National Centre for Indigenous Studies, Australian National University, Winnunga Nimmityjah Aboriginal Health Service, National Drug Research Institute, Curtin University of Technology, Sydney
2017
Bryant J; Rance J; Lafferty L; Treloar C, 2017, Annual Report of Trends in Behaviour 2017: Viral Hepatitis in Australia, Centre for Social Research in Health, UNSW Sydney, Sydney, http://dx.doi.org/10.4225/53/597ea9dc4fef2
2017
Lafferty L; Lewis S; Drysdale K; Monaghan R; Kelly-Hanku A; Guy R; Treloar C, 2023, 'Enablers and barriers to scaling up infectious diseases point-of-care testing in the primary care setting in Australia', presented at Australasian Conference on Point of Care Testing for Infectious Diseases, Sydney, 14 March 2023 - 15 March 2023
2023
Patel P; Lafferty L, 2022, 'An evaluation of MyCheck: a digital STI/BBV e-testing platform', presented at ASHM, 29 August 2022 - 01 September 2023
2022
Lafferty L; Schroeder S; Marshall A; Drysdale K; Higgs P; Stoove M; Baldry E; Dietze P; Treloar C, 2022, 'Trust and Service Engagement Among People Who Inject Drugs Post-Release', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Glasgow, Scotland, 19 October 2022 - 21 October 2022
2022
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd A; Treloar C, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
2022
Lafferty L; Rautenbach C; McNulty A; Ryder N; Slattery C; Houghton R; Kenigsberg A; Murray C; Carrington N; Patel P, 2022, 'Client and staff perceptions of acceptability of an alternative telehealth testing pathway at Sydney Sexual Health Centre for bloodborne virus and sexually transmissible infections', presented at Joint Australasian HIV&AIDS and Sexual Health Conferences, Sunshine Coast, 29 August 2022 - 01 September 2022
2022
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
2021
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
2021
Lafferty L; Rance J; Dore G; Lloyd A; Treloar C, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
2021
Lafferty L; Rance J; Treloar C, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019
2019
Lafferty L; Bryant J; Mao L; Hull P; Gray R; Treloar C, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019
2019
Rance J; Lafferty L; Treloar C, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018
2018
Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018
2018
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017
2017
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016
2016
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016
2016
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016
2016
Lafferty LM; Treloar C; Steele M; van Breda N; Hiley S; Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016
2016
Lafferty LM; Treloar C; Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016
2016
Lafferty LM; Guthrie J; Chambers GM; Butler T, 2015, 'Social capital of men in prison living with hepatitis C', presented at 2nd National Complex Needs Conference, 17 November 2015 - 18 November 2015
2015
Lafferty LM; Guthrie J; Chambers GM; Butler T, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013
2013
Lafferty LM, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013
2013
Carrington N; Patel P; Houghton R; Kenigsberg A; Slattery C; Purchas J; Prihaswan P; Browne M; Rautenbach C; Lafferty L; Murray C; Ryder N; McNulty A, 2022, 'MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers.', in MyCheck telehealth pilot: A new service modality supporting asymptomatic clients to navigate on-demand BBV/STI testing directly with commercial pathology providers., presented at ASHM, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/ae041557ba884b0ca80dffcfbded38bc
2022
Treloar C; Broady T; Drysdale K; Brener L; Schroeder SE; Lafferty L; Marshall AD; Dietze PM; Higgs P; Stoove M; Baldry E, 2022, 'Changing attitudes of the general public towards people with prison and injecting drug use histories: A research-informed, co-designed, arts-based intervention', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S136 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Salmon AM; Silins E; Belackova V; Jauncey M; Day CA; Lafferty L; Wood W, 2018, 'SYMPOSIUM: ABOVE AND BEYOND - AN EXPLORATION OF CARE BEYOND SUPERVISED INJECTIONS AT THE UNITING MEDICALLY SUPERVISED INJECTING CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S14 - S14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Rance J; Lafferty L; Treloar C, 2017, 'P52 ‘Behind closed doors, no one sees, no one knows’: stigma and treatment as prevention in prison', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 30 - 30, http://dx.doi.org/10.1016/s2055-6640(20)30793-7
2017
Lafferty L; Wild C; Rance J; Treloar C, 2017, 'P30 Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia's current policy frameworks', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 22, http://dx.doi.org/10.1016/s2055-6640(20)30771-8
2017
Lafferty L; Rance J; Treloar C, 2017, 'P31 Treatment as prevention in the prison setting: prisoners’ perspectives', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 23, http://dx.doi.org/10.1016/s2055-6640(20)30772-x
2017
Lafferty LM; Butler T, 2017, Relationships Matter: Social Capital Theory and Hepatitis C Treatment Uptake among Men in Prison, http://www.unsworks.unsw.edu.au/UNSWORKS:unsworks_search_scope:unsworks_43422
2017
Rance JA; Lafferty L; Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015
2015
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015
2015